SOURCE: Milestone Scientific, Inc.

Milestone Scientific, Inc.

May 24, 2017 07:47 ET

Milestone Scientific Hosts Webcast with U.S. Key Opinion Leader to Discuss Advantages of the Wand® Dental Instrument

LIVINGSTON, NJ--(Marketwired - May 24, 2017) - Milestone Scientific Inc . (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced a webcast presentation with Dr. David Hornbrook, DDS, FAACD, FACE, a key opinion leader (KOL) in dentistry, sharing his personal experience with the Wand® and discussing its advantages and benefits. The webcast presentation is available on the Company's website at: http://www.milestonescientific.com/investors.html.

Dr. David Hornbrook is the founder and past director of LVI, Pac--live and the Hornbrook Group. He has been a guest faculty member of the post-graduate programs in Cosmetic Dentistry at Baylor, Tufts, SUNY at Buffalo, UMKC, and the UCLA Center of Cosmetic Dentistry. Dr. Hornbrook lectures internationally on all facets of aesthetic and restorative dentistry and has published articles in all of the leading dental journals. A prolific researcher and materials enthusiast, he consults with numerous manufacturers on product development and refinement.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.

The presentation contains forward-looking statements regarding the advantages of the Wand Dental Instrument. These statements represent the views and opinions of the presenter and may not represent the prevalent views and opinions of dental professionals, presently or in the future. The views and opinions of the presenter may be affected by future results of dental professionals utilizing the device, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2016. The forward-looking statements in this presentation are based upon reasonable beliefs as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason. Please note that, from time to time, Milestone may compensate its key opinion leaders for participation in and/or attendance at sponsored events on its behalf. Any such compensation is made without regard to the opinions and conclusions expressed by any such individual.

Contact Information

  • David Waldman or Natalya Rudman
    Crescendo Communications, LLC
    Email: mlss@crescendo-ir.com
    Tel: 212-671-1020